Identification of glycolysis-related molecular subtypes and prognostic model in intrahepatic cholangiocarcinoma
The glycolysis-based risk model enables precise patient stratification and may facilitate clinical decision-making, while HMMR represents a promising therapeutic target, offering novel insights into iCCA prognosis and treatment.
Authors
- Yun‐Fan Sun (ORCID: https://orcid.org/0000-0001-9790-2761)
- Zefan Zhang (ORCID: https://orcid.org/0000-0001-5627-050X)
- Xiutao Fu
- Keqiang Rao
- Yue Wang (ORCID: https://orcid.org/0000-0001-6936-5081)
- Hui Liu (ORCID: https://orcid.org/0000-0003-0578-4062)
- Jia Fan (ORCID: https://orcid.org/0000-0001-5158-629X)
- Maohong Cao (ORCID: https://orcid.org/0000-0003-0940-467X)
- Haokang Feng
- Pengxiang Wang
Institutions
- Ministry of Education of the People's Republic of China (CN)
- Zhongshan Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1007/s12672-025-03314-4
- Citations
- 2
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- National Natural Science Foundation of China